--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About SRPT20260402P15
Pharmaceutical
Sarepta Therapeutics, Inc., was incorporated in Oregon on July 22, 1980. The Company is a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapies, gene therapies and other genetic therapies for the treatment of rare diseases. It has developed a variety of approved Duchenne muscular dystrophy treatments and is advancing drug candidates for other neuromuscular and skeletal diseases.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
